Editorial commentary: autologous platelet-rich plasma.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 25842239.
- Also identified by DOI 10.1016/j.arthro.2015.02.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Autologous platelet-rich plasma (PRP) is promising for osteoarthritis pain and may effect cartilage repair. Platelets are growth factor factories. Commercially available PRP is heterogeneous.
Medical subject headings
- Cartilage, Articular
- Intercellular Signaling Peptides and Proteins
- Osteoarthritis
- Platelet-Rich Plasma
- Regeneration